Branched Stent Grafts Market Scope
When compared to open surgical treatment of infrarenal abdominal aortic aneurysms, endovascular aortic aneurysm repair (EVAR) has been proven to lower blood loss, operative time, duration of hospital stay, mortality, and morbidity (AAAs). Short necks, severe angulation, or true aneurysm involvement of aortic side branches such as supra-aortic trunks (arch aneurysms), visceral arteries (thoracoabdominal and pararenal aneurysms), or the internal iliac arteries limit the use of EVAR in 30 to 40% of patients. Because of the complexities of their illness. Around 20% of patients with abdominal aortic aneurysms are not suitable candidates for standard endovascular surgery due to the intricacy of their condition. Complex aortic aneurysms can also affect the chest and stomach (thoracoabdominal aneurysms) as well as the aortic arch (curved portion of the aorta).
The Branched Stent Grafts market study is segmented, by Application (Thoracic Aortic Aneurysm and Aortic Dissection) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Branched Stent Grafts market throughout the predicted period.
Medtronic (Ireland), Alvimedica (Turkey), Eucatech AG (Germany), Abbott Laboratories (United States), Cardinal Health (United States), Terumo Corp. (Japan), Biotronik (Germany), Endocor GmbH (Germany), Merit Medical Systems (United States), Cook Medical (United States) and Boston Scientific Corporation (United States) are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AMA Research has segmented the market of Global Branched Stent Grafts market by Type, Application and Region.
On the basis of geography, the market of Branched Stent Grafts has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Singapore, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Spain, Rest of Europe), MEA (Saudi Arabia, Turkey, Israel, United Arab Emirates, South Africa, Rest of Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
On Nov. 20. 2021 - Terumo Corporation announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalised vascular therapy.
- Increasing Innovations in Medical Technologies
- Increase in the Number of Endovascular Aneurysm Repair
- Increasing Geriatric Population As Well As High Prevalence of AAA
- Increasing Demand for Minimally Invasive Surgical Procedures
- Reduction in Growth Rate, and Deferring Of Elective Surgeries Caused by the Outbreak of Novel Corona Virus
Key Target AudienceManufacturers of Medical Device, Suppliers of Medical Device, Wholesalers, Distributors and Retailers of Medical Device, Healthcare Industry and Others
Frequently Asked Questions (FAQ):
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
2. How big is the Branched Stent Grafts Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.